HIV Prevention Drug Uptake Threatened in Obamacare Battle

HIV-prevention treatment costs have been an on-and-off burden for Henry Henderson over the past six years.

Pre-exposure prophylaxis medication, or PrEP as it’s more commonly known, has been “a godsend,” Henderson said. A child of the ‘90s, an era when AIDS became the leading cause of death for young Americans, he can’t understate the “peace of mind and feeling free not to worry much” about contracting HIV.

But early on, a trip to the doctor could run him $100 to $300, forcing Henderson to run a “cost-benefit analysis” before every visit. That’s despite the Affordable Care Act’s requirement that private ...